Strategic Funding ATP is a life sciences venture powerhouse actively funding and building companies from pre-IP ideas to asset spinouts, with flexible capital and a connection to a world-class team. Sales opportunities: offer specialized biotech investment services, strategic partnerships, and co-investment structures aligned with their growth stages.

Portfolio Expansion Recent activity includes investments in Red Queen Therapeutics, Deep Apple Therapeutics, Deepappletx, Aulos Bioscience, and Ascidian Therapeutics. Sales opportunities: present platforms or services that accelerate drug discovery, RNA editing, or immuno-oncology programs and support for Series A to beyond.

Tech Enablement ATP emphasizes structure-based virtual screening, deep learning models, and lab-to-market acceleration through Deep Apple Therapeutics. Sales opportunities: offer AI/ML drug discovery tools, high-throughput screening platforms, data analytics services, and computational biology collaborations.

Geographic/Network Reach Based in New York with a broad ecosystem footprint in life sciences investing and co-investor syndication, including notable collaborators. Sales opportunities: provide clinical development services, regulatory strategy consultants, and partner ecosystem introductions to biopharma, academic spinouts, and service providers.

Funding & Scale Reported revenue range and high-profile co-investors indicate capacity to deploy significant capital across multiple rounds. Sales opportunities: propose strategic consulting, fundraising advisory, and scalable CRO/CDMO partnerships aligned with late-stage financing, scale-up manufacturing, and global clinical trials.